Researchers inch toward a vaccine for Alzheimer's disease

01/17/2013 | Salon

Researchers at Université Laval and GlaxoSmithKline are reporting success in using monophosphoryl lipid A to stimulate the nervous system's immune response to Alzheimer's disease in mice. Weekly injections of MPL over 12 weeks eliminated up to 80% of brain plaques and improved the mice's cognitive function, researchers say. GSK has used the molecule as a vaccine adjuvant for years.

View Full Article in:

Salon

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA
Actuary
NTA Life
Addison, TX
Chief Information Officer
Meridian Health Plan
Detroit, MI
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA